Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

Rainer Storb(City Of Hope National Medical Center), Brenda M. Sandmaier(University of Washington), Mohamed L. Sorror(University of Washington Medical Center), George E. Georges(Fred Hutch Cancer Center), Marco Mielcarek(Fred Hutch Cancer Center), Mary E.D. Flowers(City Of Hope National Medical Center), David G. Maloney(Fred Hutch Cancer Center), Wolfgang Bethge(University of Tübingen), Firoozeh Sahebi(City Of Hope National Medical Center), Parameswaran Hari(Medical College of Wisconsin), Benedetto Bruno(University of Turin), Dietger Niederwieser(Leipzig University of Applied Sciences), Thomas R. Chauncey(City Of Hope National Medical Center), Ann E. Woolfrey(University of Washington), Amelia Langston(CancerCare Manitoba), Paul J. Martin(European Society for Blood and Marrow Transplantation), Boglarka Gyurkocza(Cornell University), Barry E. Storer(City Of Hope National Medical Center), Ginna G. Laport(Stanford Blood Center), Richard T. Maziarz(Oregon Health & Science University), Kai Hübel(University Hospital Cologne), Andrew M. Yeager(University of Arizona), Peter A. McSweeney(Colorado Blood Cancer Institute), Lars L. Vindeløv(University of Copenhagen), Finn Bo Petersen(Intermountain Healthcare), Edward Agura(Baylor University), Karl G. Blume(City Of Hope National Medical Center), Georg‐Nikolaus Franke(University Hospital Leipzig), Michael A. Pulsipher(Children's Hospital of Los Angeles), Michael B. Maris(Colorado Blood Cancer Institute), H. Joachim Deeg(University of Washington)
Journal of Clinical Oncology
March 12, 2013
Cited by 212


Related Papers